Veterinary Vaccines Market Measurement to Attain USD 12.75 Billion by 2027

Ad Blocker Detected

Our website is made possible by displaying online advertisements to our visitors. Please consider supporting us by disabling your ad blocker.

Key players in the veterinary vaccine market include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA. SA

Vancouver, British Columbia, February 10, 2021 (GLOBE NEWSWIRE) – According to a recent analysis by Emergen Research, the global veterinary vaccine market is expected to reach $ 12.75 billion by 2027 and grow at a CAGR of 6.9%. During the forecast period, the global veterinary vaccine market is expected to grow significantly due to the increasing demand for animal products that are safe for human consumption. In addition, the increasing trend in pet adoption is expected to continue to fuel the veterinary vaccine market over the forecast period.

Request your FREE sample copy with table of contents @

In addition, the increased use of veterinary vaccines to process food safely and efficiently is expected to fuel the global veterinary vaccine market in the near future. Veterinary vaccines are used in farm animals and poultry to improve animal health and increase overall production. Increasing food production requires more productive animal processing and better access to high quality protein.

The lower research and development spending on veterinary vaccines is likely to constrain the global veterinary vaccines market to some extent during the forecast period.

Top Companies Profiled In The Veterinary Vaccines Market Report Are:

Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Inc., Dechra Pharmaceuticals PLC and Laboratorios HIPRA, SA

Key highlights of the report

  • In May 2018, Abaxis, Inc. was acquired by Zoetis Inc. With this move, Zoetis would be able to offer its veterinary customers comprehensive solutions to predict, prevent, diagnose and treat diseases in animals.

  • For the forecast period, the dog segment is expected to grow the fastest. An increasing dog population and an increase in the risk of death for rabies will lead to higher levels of vaccination services, which would encourage routine dog vaccinations. This in turn is likely to boost the dog segment in the near future.

  • For the forecast period, significant growth is expected for the oral segment with a CAGR of 6.9%. Improving the immunity of farm animals is the main goal of oral vaccines. The increasing demand for poultry products and high-quality meat should stimulate the oral segment in the forecast period.

  • The toxoid segment is likely to grow significantly over the forecast period due to the benefits of toxoid vaccines such as low risk of infection, lower resistance to moisture variability, and better stabilization.

  • The parasitic segment is likely to experience significant growth in the forecast period. Zoonotic and foodborne parasite vaccines are critical to improved food production that is expected to fuel the segment over the next several years.

  • The Asia Pacific market is expected to experience the fastest growth over the forecast period, with an increase in animal populations, particularly in developing countries in the region.

Check our prices @
Emergen Research has segmented the global Veterinary Vaccine Market by Type, Route of Administration, Technology, Infection, and Region.

The story goes on

  • Type Outlook (Revenue, Billion USD; 2017-2027)

    • poultry

    • pig

    • Aquaculture

    • Cattle

    • cat

    • dog

  • Management Trail Outlook (Revenue, $ Billion; 2017-2027)

    • Orally

    • injection

    • Spray / dip

  • Technology Outlook (Revenue, $ Billion; 2017-2027)

    • Inactivated

    • Live attenuated

    • Recombinant

    • Toxoid

  • Infection Outlook (Revenue, $ Billion; 2017-2027)

    • mushroom

    • bacteria

    • Parasitic

    • Viral

Click here to access the report study, read the report’s key highlights, and view the projected trends:

Check out our related reports:

Topical Drug Delivery Market by Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Other), By End Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Centers), and By Regions

Smart Medical Textiles Market by Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-monitoring, Therapy, and Wellness), By Purpose (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Market for OR Management Solutions Market by Solution Type (Data Management and Communication Solutions, Solutions for OR Supply Management, Solutions for Anesthesia Information Management, OR Planning Solutions, Performance Management Solutions), by Deployment Mode (Whether-Premises, Cloud-Based) , By intended use (hospitals, outpatient surgical centers) and by region

Patient Registration Software Market By Shipment, By Database, By Registration Type, By Function, By Software Type (Integrated, Standalone), By Purpose (Government And Third Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, etc.), And By Regions, Forecast To 2027

Outpatient EHR Market by Deployment (Cloud-Based, On-Premises), By Practice Size (Individual Practices, Large Practices, Small to Medium-Sized Practices), By Application, By Purpose (Independent Centers, Outpatient Hospital Centers, Others), and By Region Forecasts to 2027

About Emergen Research

Emergen Research is a market research and advisory firm that provides syndicated research reports, bespoke research reports, and advisory services. Our solutions focus solely on your purpose of locating, targeting, and analyzing changes in consumer behavior across a variety of demographic and cross-industry sectors, and helping customers make smarter business decisions. We offer market research studies that ensure relevant and fact-based research across various industries including healthcare, touchpoints, chemicals, types, and energy. We are constantly updating our research offerings to ensure that our customers are aware of the latest trends in the market. Emergen Research has a strong base of experienced analysts from various fields. Our industry experience and the ability to develop a specific solution for all research problems offer our customers the opportunity to secure an advantage over their respective competitors.

Contact us:

Eric Lee

Corporate sales specialist

Emergen Research | Web:

Direct line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read the full press release: